Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, +24

Nature Medicine

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

Nicholas Salgia, Paulo Gustavo Bergerot, Manuel Caitano Maia, +8

European Urology

DysbiosisStool Microbiome ProfilingCancer ImmunosurveillanceImmunologyPathology +4

Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

Nazlı Dizman, Yung Lyou, Nicholas Salgia, +7

Journal for ImmunoTherapy of Cancer

Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status

Cristiane Decat Bergerot, Errol J. Philip, Paulo Gustavo Bergerot, +9

Cancer

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

Alex Chehrazi‐Raffle, Luís Meza, Marice Alcantara, +10

Journal for ImmunoTherapy of Cancer

Unmasking Arrhythmogenic Hubs of Reentry Driving Persistent Atrial Fibrillation for Patient‐Specific Treatment

Brian J. Hansen, Jichao Zhao, Katelynn M. Helfrich, +20

Journal of the American Heart Association

Cardiac MuscleEngineeringCardiovascular PharmacologyBackground Atrial FibrillationBiomedical Engineering +24

Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma

Zeynep Büşra Zengin, Caroline Weipert, Nicholas Salgia, +16

Clinical Cancer Research

Barriers to Clinical Trial Implementation Among Community Care Centers

Hedyeh Ebrahimi, Sandra Megally, Elana Plotkin, +18

JAMA Network Open

First results of a randomized phase IB study comparing nivolumab/ipilimumab with or without CBM-588 in patients with metastatic renal cell carcinoma.

Luís Meza, Nazlı Dizman, Paulo Gustavo Bergerot, +17

Journal of Clinical Oncology

DysbiosisMicrobial PathogensImmunologyPharmacotherapyProbiotic +21

Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances

Nicholas Salgia, Zeynep Büşra Zengin, Sumanta K. Pal, +1

American Society of Clinical Oncology Educational Book